Millipore Sigma Vibrant Logo

MABN1835 Anti-DYRK1A Antibody, clone 7F3

View Products on Sigmaaldrich.com
MABN1835
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, Mk, RIH(P), WB, IF, ICCMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABN1835
      DescriptionAnti-DYRK1A Antibody, clone 7F3
      Alternate Names
      • Dual specificity tyrosine-phosphorylation-regulated kinase 1A
      Background InformationDual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2; UniProt Q63470; also known as Dual specificity YAK1-related kinase, MNBH, Protein kinase minibrain homolog, RP86) is encoded by the Dyrk1a (also known as Dyrk) gene (Gene ID 25255) in rat species. DYRK1A belongs to a family of conserved dual-specificity tyrosine-phosphorylated and regulated kinases (DYRKs) within the CMGC (CDK, MAPK, GSK, and CLK) group of eukaryote kinome. DYRK family members share a conserved kinase domain and an adjacent DYRK-homology domain or DH-box (DDDNXDY), wihile differing in their N- and C-terminal regions. DYRK1A is regulated by autophosphorylation on Ser, Thr and Tyr residues, but catalyzes phosphorylation of a broad-range of substrates only on Ser/Thr residues within the RPX(S/T)P motif with a preference for Pro at the +1 position (X). Known DYRK1A substrates include transcription factors (e.g. FKHR, CREB, Gli1, NFAT), splicing factors (e.g. cycling L2, SF3b/SAP155), glycogen synthase, as well as multiple proteins engaged in endocytosis in neurons, including dynamin and synaptojanin 1. DYRK1A is also implicated in promoting the formation of neurotoxic Aβ peptides by phosphorylating APP and presenilin-1. Human DYRK1A gene is located in the Down syndrome critical region of chromosome 21 and the protein plays an essential role in the development of the central nervous system. DYRK1A haploinsufficiency and mutations are the causes of intellectual disability (ID), microcephaly and dysmorphic features in human, while transgenic mice carrying extra copies of the gene exhibit learning defects and motor abnormalities.
      References
      Product Information
      FormatPurified
      PresentationPurified mouse IgG2bκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-DYRK1A, clone 7F3, Cat. No. MABN1835, is a highly specific mouse monoclonal antibody that targets DYRK1A and has been tested in Immunocytochemistry, Immunofluorescence, Immunohistochemistry, and Western Blotting.
      Key Applications
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      • Immunofluorescence
      • Immunocytochemistry
      Application NotesImmunohistochemistry Analysis: A 1:50 dilution from a representative lot detected DYRK1A in rat thalamus tissue section.

      Immunocytochemistry Analysis: A representative lot, pre-conjugated with Alexa Fluor® 568, immunostained the soma and processes of 2% formaldehyde-fixed, 0.05% saponin-permeabilized E-18 rat hippocampal neurons by fluorescent immunocytochemistry. DYRK1A immunoreactivity was more abundant in nuclei than in the cytoplasm. Co-localization of DYRK1A and clathrin heavy chain (CHC) immunoreactivity was very prominent in the processes and less significant in the soma (Murakami, N., et al. (2012). PLoS One. 7(4):e34845).

      Immunofluorescence Analysis: A representative lot detected DYRK1A cellular localization in GFAP-positive astrocytes and in vimentin-positive endothelial cells by dual fluorescent immunohistochemistry staining of 10% formalin-fixed, PEG 1000-embeded human brain tissue sections (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).

      Immunohistochemistry Analysis: A representative lot detected DYRK1A immunoreactivity in paraffin-embedded fetal (20-week gestation) Down syndrome (DS) white matter associated with structures resembling the omnipresent cytoskeleton filamentous network in axons (Dowjat, K., et al. (2012). J. Neuropathol. Exp. Neurol. 71(12):1100-1112).

      Immunohistochemistry Analysis: A representative lot detected age- and brain region-dependent DYRK1A immunoreactivity in 10% formalin-fixed, PEG 1000-embeded human brain tissue sections (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).

      Western Blotting Analysis: A representative lot detected both endogenous monkey DYRK1A and exogenously expressed full-length rat DYRK1A in COS-7 cells, as well as DYRK1A in human hippocampus tissue extracts. Antibody blocking with the immunogen prior to Western blotting abolished target band detection (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).
      Biological Information
      ImmunogenHis-tagged recombinant rat DYRK1A N-terminal fragment (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).
      Clone7F3
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityThe specificity of target band detection was confirmed by antibody blocking with the immunogen prior to Western blotting (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).
      IsotypeIgG2bκ
      Species Reactivity
      • Human
      • Monkey
      • Rat
      Species Reactivity NoteHuman, Monkey, Rat.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • Dyrk1a
      • Dyrk
      Purification MethodProtein G purified.
      UniProt Number
      Molecular Weight85.58/84.56/60.33/61.77/66.10 kDa (human isoform Long/1/2/3/4), 85.49 kDa (mouse), 85.54/84.51 kDa (rat isoform 1/2) calculated. ~90 kDa doublet reported (Wegiel, J., et al. (2004). Brain Res. 1010(1-2):69-80).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Immunohistochemistry in rat cerebellum tissue section.

      Immunohistochemistry Analysis: A 1:50 dilution of this antibody detected DYRK1A in rat cerebellum tissue section.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABN1835 04054839105487